A detailed history of Lee Danner & Bass Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lee Danner & Bass Inc holds 32,101 shares of BMY stock, worth $1.85 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
32,101
Previous 31,532 1.8%
Holding current value
$1.85 Million
Previous $1.31 Million 26.79%
% of portfolio
0.12%
Previous 0.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$39.66 - $51.75 $22,566 - $29,445
569 Added 1.8%
32,101 $1.66 Million
Q2 2024

Jul 30, 2024

SELL
$40.25 - $52.99 $576,420 - $758,869
-14,321 Reduced 31.23%
31,532 $1.31 Million
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $1.19 Million - $1.42 Million
-24,621 Reduced 34.94%
45,853 $2.35 Million
Q3 2023

Oct 27, 2023

SELL
$57.89 - $64.73 $130,599 - $146,030
-2,256 Reduced 3.1%
70,474 $4.09 Million
Q2 2023

Jul 31, 2023

SELL
$63.71 - $70.74 $147,807 - $164,116
-2,320 Reduced 3.09%
72,730 $4.65 Million
Q1 2023

May 02, 2023

SELL
$65.71 - $74.53 $12,484 - $14,160
-190 Reduced 0.25%
75,050 $5.2 Million
Q4 2022

Feb 01, 2023

SELL
$68.48 - $81.09 $15,476 - $18,326
-226 Reduced 0.3%
75,240 $5.41 Million
Q3 2022

Oct 31, 2022

SELL
$0.13 - $76.84 $67 - $39,726
-517 Reduced 0.68%
75,466 $5.37 Million
Q2 2022

Jul 25, 2022

SELL
$72.62 - $79.98 $82,423 - $90,777
-1,135 Reduced 1.47%
75,983 $5.85 Million
Q1 2022

Apr 27, 2022

SELL
$61.48 - $73.72 $108,512 - $130,115
-1,765 Reduced 2.24%
77,118 $5.63 Million
Q4 2021

Jan 27, 2022

SELL
$53.63 - $62.52 $433,062 - $504,849
-8,075 Reduced 9.29%
78,883 $4.92 Million
Q3 2021

Nov 01, 2021

BUY
$59.17 - $69.31 $249,283 - $292,003
4,213 Added 5.09%
86,958 $5.15 Million
Q2 2021

Jul 27, 2021

SELL
$61.91 - $67.42 $91,131 - $99,242
-1,472 Reduced 1.75%
82,745 $5.53 Million
Q1 2021

Apr 29, 2021

BUY
$59.34 - $66.74 $22,430 - $25,227
378 Added 0.45%
84,217 $5.32 Million
Q4 2020

Feb 09, 2021

SELL
$57.74 - $65.43 $78,468 - $88,919
-1,359 Reduced 1.6%
83,839 $5.2 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $294,041 - $325,836
-5,120 Reduced 5.67%
85,198 $5.14 Million
Q2 2020

Aug 10, 2020

BUY
$54.82 - $64.09 $1.36 Million - $1.59 Million
24,849 Added 37.96%
90,318 $5.31 Million
Q1 2020

May 04, 2020

BUY
$46.4 - $67.43 $166,808 - $242,410
3,595 Added 5.81%
65,469 $3.65 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $843,262 - $1.1 Million
17,136 Added 38.3%
61,874 $3.97 Million
Q3 2019

Oct 30, 2019

BUY
$42.77 - $50.71 $4,277 - $5,071
100 Added 0.22%
44,738 $2.27 Million
Q1 2019

May 06, 2019

SELL
$45.12 - $53.8 $7,896 - $9,415
-175 Reduced 0.39%
44,638 $2.13 Million
Q4 2018

Jan 29, 2019

SELL
$48.76 - $63.23 $19,650 - $25,481
-403 Reduced 0.89%
44,813 $2.33 Million
Q3 2018

Nov 06, 2018

SELL
$55.19 - $62.25 $6,898 - $7,781
-125 Reduced 0.28%
45,216 $2.81 Million
Q1 2018

May 02, 2018

BUY
$59.92 - $68.98 $179 - $206
3 Added 0.01%
45,341 $2.87 Million
Q4 2017

Feb 02, 2018

SELL
$59.94 - $65.35 $117,842 - $128,478
-1,966 Reduced 4.16%
45,338 $2.78 Million
Q3 2017

Oct 27, 2017

BUY
$55.23 - $63.74 $2.61 Million - $3.02 Million
47,304
47,304 $3.02 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lee Danner & Bass Inc Portfolio

Follow Lee Danner & Bass Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Danner & Bass Inc, based on Form 13F filings with the SEC.

News

Stay updated on Lee Danner & Bass Inc with notifications on news.